Pancreatic Cancer Research

ResearcherPeking University First HospitalActive in the last 2 years

Dongqi Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5121941883. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2026: 2 papers

Papers 2

  1. Exosomal miR-4644 Targets SPRY3 to Promote Proliferation and Invasion of Pancreatic Cancer. First author DOI 10.1002/cam4.72000↗
  2. The Acidic Exosomal miR-1246/WASF3 Axis Regulates Hepatic Stellate Cell Activation and Stiff ECM Remodeling to Promote Pancreatic Ductal Adenocarcinoma Liver M… Co-author DOI 10.7150/ijbs.132772↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangyu Chu · 2 shared papers, 2026 · strength 0.58
  2. Yinmo Yang · 2 shared papers, 2026 · strength 0.58
  3. Xiaodong Tian · 1 shared paper, 2026 · strength 0.30
  4. Yongsu Ma · 1 shared paper, 2026 · strength 0.30
  5. Xiaodong Tian · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.